News | April 09, 2026
OPPI and NIPER Raebareli partner to boost pharma research and talent
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
The new capital is expected to fund the company through 2029
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Subscribe To Our Newsletter & Stay Updated
